CT-102(Cura Therapeutics)

N/A

Report date: 2022/12/26 15:26:41

Base Information

Drug NameCT-102(Cura Therapeutics)
Drug Alias NameCT-102(Cura Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCura Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCura Therapeutics
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A